Updated Results for Infigratinib in Metastatic Urothelial Cancer

Researchers reported updated findings of infigratinib in upper tract urothelial carcinoma and urothelial carcinoma of the bladder, supporting the development of phase III studies in this setting.

Source: CancerNetwork - April 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news